| 书目名称 | Leading Pharmaceutical Innovation | | 副标题 | Trends and Drivers f | | 编辑 | Oliver Gassmann,Gerrit Reepmeyer,Maximilian Zedtwi | | 视频video | | | 概述 | The book is based on the three most important challenges in pharmaceutical innovation: productivity dilemma, new technology trends, globalization and outsourcing.Due to the CTO-roundtable with 14 sele | | 图书封面 |  | | 描述 | Pharmaceutical innovation is like gambling at roulette, only the stakes are higher. Considerably higher, since the most recent estimates put the costs of drug development at US$ 800 million to US$ 1 billion - per drug! This is equivalent to the price tag of the Empire State Building, when it was for sale a few years ago. In 2001, the major US and European pharmaceutical companies invested more than US$ 30 billion in R&D, at a higher R&D to-sales ratio than virtually any other industry, including chemicals, auto mobiles, electronics, aerospace, and computers. Delivering a blockbuster drug is the Holy Grail for any pharmaceutical company. But in the last decade the rules of developing blockbusters seem to have changed. On the one hand, more sophisticated screening technolo gies, genetic engineering, and expanding networks with biotechnology companies increase the probability of commercial success. Critical success factors include the discovery phase and a stronger outside-in orientation in the early innovation phase. After the implosion of the high-tech stock mar ket, biotechnology and other technology-driven opportunities may have lost some of their attractiveness for big pharma | | 出版日期 | Book 20041st edition | | 关键词 | Drug Discovery; Forschung & Entwicklung; Globalization; Innovation Management; Pharmaceuticals; Productiv | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-540-24781-4 | | isbn_ebook | 978-3-540-24781-4 | | copyright | Springer-Verlag Berlin Heidelberg 2004 |
The information of publication is updating
|
|
发表于 2025-3-21 18:27:37
